APA (7th ed.) Citation

A, K., T, B., C, P., KK, S., N, C., JJ, d. M., . . . L, M. (2024). Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): An open-label, randomised, phase 2 study. Lancet (London, England), 404(10452), 527. https://doi.org/10.1016/S0140-6736(24)00814-6

Chicago Style (17th ed.) Citation

A, Krämer, et al. "Molecularly Guided Therapy Versus Chemotherapy After Disease Control in Unfavourable Cancer of Unknown Primary (CUPISCO): An Open-label, Randomised, Phase 2 Study." Lancet (London, England) 404, no. 10452 (2024): 527. https://doi.org/10.1016/S0140-6736(24)00814-6.

MLA (9th ed.) Citation

A, Krämer, et al. "Molecularly Guided Therapy Versus Chemotherapy After Disease Control in Unfavourable Cancer of Unknown Primary (CUPISCO): An Open-label, Randomised, Phase 2 Study." Lancet (London, England), vol. 404, no. 10452, 2024, p. 527, https://doi.org/10.1016/S0140-6736(24)00814-6.